Gossamer Bio Inc
(NAS:GOSS)
$
0.6981
-0.0036 (-0.51%)
Market Cap: 158.19 Mil
Enterprise Value: 34.78 Mil
PE Ratio: 0
PB Ratio: 2.92
GF Score: 36/100 Gossamer Bio Inc at Bank of America Healthcare Conference Transcript
May 11, 2022 / 05:00PM GMT
Release Date Price:
$7.21
(+0.70%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Welcome to the second day of the Bank of America Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here, and we're thrilled to have Gossamer Bio, and on stage with me is Faheem Hasnain, who is Chairman and CEO; and Richard Aranda, who's not Chief Marketing Officer.
Faheem Hasnain
Gossamer Bio, Inc. - Co-Founder, CEO, President & Chairman
Although I think you would like that.
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Yes, exactly.
Richard Aranda
Gossamer Bio, Inc. - Chief Medical Officer
It's an upgrade.
Questions & Answers
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Exactly. Let's kick it off then Faheem with sort of a bigger picture. So when you guys founded Gossamer the idea was to have different therapeutic areas and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot